Company Data

CytoMed Therapeutics Limited

Ticker
GDTC
Current Price
$2.8 1.82%
Market Cap
$32.3M
Price Target
Refer to Report
Volume
9.6K
52wk Range
$1.2 - $4.0499
Advanced Market Data

Overview

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy